(11659441), N. S., (11659459), M. Y. K., (21322907), M. A. A. W., (11659456), A. S. M., (21322910), A. A. A., (21322913), A. G. M. T., . . . (11659453), A. J. N. (2022). Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial).
Chicago Style (17th ed.) Citation(11659441), Nissar Shaikh, Mohamad Y. Khatib (11659459), Mohammad A. Al Wraidat (21322907), Ahmed S. Mohamed (11659456), Anood A. Al-Assaf (21322910), Abdul Gafoor M. Tharayil (21322913), Ahmad A. Abujaber (14586054), and Abdulqadir J. Nashwan (11659453). Nebulized Fentanyl for Respiratory Symptoms in Patients with COVID-19 (ventanyl Trial). 2022.
MLA (9th ed.) Citation(11659441), Nissar Shaikh, et al. Nebulized Fentanyl for Respiratory Symptoms in Patients with COVID-19 (ventanyl Trial). 2022.